Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Safety Profile in Patients with Chronic Lymphocytic Leukemia Undergoing Treatment with 1st and 2nd Generation Bruton Tyrosine Kinase Inhibitors: Multicentric Real-World Experience

Alberto Lopez Garcia, Alfonso Garcia, Ester Macia, Daniel Morillo, Carolina Miranda, Laura Bermejo, Maria Yuste, Maria Pilar Llamas Sillero, Raul Cordoba

Blood (2023) 142 (Supplement 1): 6551.

https://doi.org/10.1182/blood-2023-181722

Published: 2023

Journal Articles

Feasibility of Electronic Patient-Reported Outcome (ePRO) Measurement Using PRO-CTCAE® Questionnaire to Improve Quality of Life Assessment and Healthcare Resources Management in Patients with Lymphoma Receiving Intravenous Chemotherapy

Sergio Ramos-Cillan, Natalia Barreras Ruiz, Adriana Pascual, Eva Castillo Bazan, Miriam Riesco Ovelar, Celia Urrutia, Antonio Herrero, Susana Cruz, Alberto Pardo, Alberto Lopez-Garcia, Maria Angeles Perez-Saenz, Daniel Murillo, María Pilar Llamas Sillero, Javier Becares, Carla Barriocanal, Marta del Olmo, Jorge Short Apellaniz, Javier Arcos Campillo, Raul Cordoba

Blood (2022) 140 (Supplement 1): 10987–10988.

https://doi.org/10.1182/blood-2022-157481

Published: 2022

Journal Articles

Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021

Blood (2022) 140 (Supplement 1): 10965–10966.

https://doi.org/10.1182/blood-2022-167155

Published: 2022

Journal Articles

End-of-Life Care in Hospitalized Patients with Hematologic Malignancies: A Retrospective Unicentric Study

Alberto Lázaro García, Marta González Rodríguez, Edwin Uriel Suárez Merchán, Gonzalo Castellanos Arias, Alicia de las Heras Moreno, María Pilar Llamas Sillero, Eduardo García Romo, Antonio Noguera Tejedor, Laura Solán Blanco, Antonio Herrero, Juan Manuel Alonso Dominguez

Blood (2022) 140 (Supplement 1): 8094–8095.

https://doi.org/10.1182/blood-2022-165525

Published: 2022

Journal Articles

Machine Learning Model Defines Higher Risk of Venous Thromboembolism in Young Adults with Multiple Myeloma

Inés Martínez-Alfonzo, Diego Velasco, Pablo Mínguez Paniagua, Ignacio Mahillo-Fernández, Elham Askari, Rosa Vidal Laso, Cristina Fernández Maqueda, Alberto Velasco, Ana González-Teomiro, Maria Civeira-Marín, Elena Prieto-Pareja, Sara Martín-Herrero, José Manuel Calvo Villas, Isabel Krsnik, Joaquín Sánchez-Garcia, Miguel Angel Alvarez, María Pilar Llamas Sillero, Juana Serrano-López

Blood (2022) 140 (Supplement 1): 2811–2812.

https://doi.org/10.1182/blood-2022-167058

Published: 2022

Journal Articles

Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy

Blood (2022) 140 (Supplement 1): 5164–5166.

https://doi.org/10.1182/blood-2022-159076

Published: 2022

Journal Articles

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies

Joaquin Martinez Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Celina Benavente Cuesta, Lauren Benito, jose Angel Hernandez, Maria Regina Herraez, Pilar Herrera Puente, Mi Kwon, Keina Quiroz, Andres Arroyo, Adrian Alegre, María Pilar Llamas Sillero, Javier López Jiménez, Pedro Sanchez-Godoy, Rafael F. Duarte, Jose L. Diez Martin, Víctor Jiménez-Yuste, Julio Garcia-Suarez

Blood (2022) 140 (Supplement 1): 7924–7925.

https://doi.org/10.1182/blood-2022-169545

Published: 2022

Journal Articles

Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study

Blood (2021) 138 (Supplement 1): 186.

https://doi.org/10.1182/blood-2021-152539

Published: 2021

Journal Articles

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Paola Alejandra Barzallo Burbano, Mar Meijón, Nuria Revilla Calvo, María Jesús Blanco Bañares, Begoña Fernández, Ramón Rodríguez-González, María Elena Sola Aparicio, Belén Rosado Sierra, Susana Asenjo Correa, Isabel Gutiérrez, María Pilar Llamas Sillero, José L. Díez-Martín, Gloria Pérez-Rus, Cristina Pascual Izquierdo

Blood (2021) 138 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2021-152962

Published: 2021

Journal Articles

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

Rebeca Bailén, MD, Mi Kwon, MD PhD, Beatriz Aguado, MD, Rafael F. Duarte, MD PhD FRCP, Maria Calbacho, MD, Anabelle Chinea, MD, Pilar Llamas, MDPhD, Rosalía Riaza Grau, Jose Angel Hernandez-Rivas, MD PhD, Victor Jimenez Yuste, MD PhD, Carmen Martínez-Chamorro, MD, F. Javier Penalver, MD, Ataulfo González, MD, Juan F del Campo, Keina Quiroz, MD, Gillen Oarbeascoa, MD, Julio Garcia Suarez, José Luis Díez-Martín, MD PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-138728

Published: 2020

Journal Articles

Study of the Clinical Significance of the Length of FLT3-ITD in Acute Myeloid Leukemia Patients

Tamara Castaño, MD, Rosa Ayala, MD PhD, Maria Pilar Llamas Sillero, Joaquin Martinez Lopez, MD, Rocio N Salgado, PhD, Mireia Atance, Jose Luiz Lopez Lorenzo, MD, Jose F. Tomas, MD PhD, Carlos Blas, MD, Juan Manuel Alonso Dominguez, MD PhD MSc

Blood (2018) 132 (Supplement 1): 5278.

https://doi.org/10.1182/blood-2018-99-115164

Published: 2018

Journal Articles

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Raul Cordoba, MD PhD, Ana-Isabel Hormigo, MD, Javier Martinez-Peromingo, MD, Maria Jarana, RN, Marta Perez-Albacete, RN, Teresa Villaescusa, MD PhD, Elham Askari, MD, Jose Luiz Lopez Lorenzo, MD, Maria Angeles Perez-Saenz, MD PhD, Elena Prieto, MD, Maria Pilar Llamas Sillero, MD PhD

Blood (2018) 132 (Supplement 1): 4753.

https://doi.org/10.1182/blood-2018-99-116950

Published: 2018

Journal Articles

Inhibition of the Hedgehog Pathway Decreases the Quiescent CD34+CD38- Population in Acute Myeloid Leukemia

Alicia Arenas, Daniel Lainez, Cristina Serrano del Castillo, MD, Rocio N Salgado, PhD, Carlos Blas, MD, Mireia Atance, Raul Cordoba, MD PhD, Pilar Llamas, MD PhD, Juan Manuel Alonso Dominguez, MD PhD MSc

Blood (2018) 132 (Supplement 1): 1509.

https://doi.org/10.1182/blood-2018-99-118636

Published: 2018

Journal Articles

Comparation of Digital PCR and Quantitative Pcr for Molecular Monitorization of Chronic Myeloid Leukemia Patients

Juan Manuel Alonso Dominguez, MD PhD MSc, Rodrigo Iñiguez Garcia, MD, Susana Olmedillas, PhD, Rocio N Salgado, PhD, Tamara Castaño, MD, Carlos Blas, MD, Diego Velasco Rodrgiguez, MD PhD, Gala Vega, MD, Jose Luis Lopez Lorenzo, MD, Pilar Giraldo, PhD, Joaquin Martinez Lopez, MD PhD, Pilar Llamas, MDPhD, Mireia Atance, Arantxa Garcías Raso

Blood (2017) 130 (Supplement 1): 2891.

https://doi.org/10.1182/blood.V130.Suppl_1.2891.2891

Published: 2017

Journal Articles

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Juan Manuel Alonso Dominguez, MD PhD MSc, Alicia Arenas, PhD, Pilar Llamas, MDPhD, Diego Velasco, Aránzazu García-Raso, PhD, Jose Luis Lopez Lorenzo, MD, Mireia Atance, Rocio N Salgado, PhD, Joaquin Martinez Lopez, MD PhD

Blood (2017) 130 (Supplement 1): 5245.

https://doi.org/10.1182/blood.V130.Suppl_1.5245.5245

Published: 2017

Journal Articles

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Darrko Antic, Mihaljevic Biljana, Natasa Milic, Bruce D. Cheson, MD, Mayur Narkhede, MD, Irina Panovska, Sanja Trajkova, Marija Popova, Pilar Llamas, MDPhD, Arantxa Garcías Raso, Aurelien Delluc, MD PhD, Jean-Christophe Ianotto, MD, Grigorios T. Gerotziafas, MD PhD, Jawed Fareed, PhD

Blood (2017) 130 (Supplement 1): 558.

https://doi.org/10.1182/blood.V130.Suppl_1.558.558

Published: 2017

Journal Articles

Analysis of Primary Hemostasis Alterations Induced By Ibrutinib Assessed By Shutter Speed and Aggregometry Impedance

Raul Cordoba, MD PhD, Rosa Vidal, MD, Aranzazu Garcia-Raso, PhD, Tamara Castaño, MD, Carlos Plaza, MD, Elham Askari, MD, Maria-Angeles Perez, MD PhD, Valentin Garcia Gutierrez, MD PhD, Pilar Llamas, MD PhD

Blood (2016) 128 (22): 4931.

https://doi.org/10.1182/blood.V128.22.4931.4931

Published: 2016

Journal Articles

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

Juan Manuel Alonso-Dominguez, MD, Felipe Casado, MariaTeresa Gómez Casares, MDPhD, Ismael Buno, Francisca Ferrer-Marin, Eduardo Anguita, MD PhD, Alicia Arenas, Rafael Del Orbe, MD, Rosa M. Ayala, MD PhD, Pilar Llamas, MD, Pedro Sanchez-Godoy, MD, Carmen Burgaleta, MD, Valentín García-Gutierrez, Juan Luis Steegmann, MD PhD, Joaquin Martinez-Lopez

Blood (2015) 126 (23): 2791.

https://doi.org/10.1182/blood.V126.23.2791.2791

Published: 2015

Journal Articles

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

Rebeca Manso, Margarita Sánchez-Beato, Silvia Monsalvo, Sagrario Gómez, Laura Cereceda, Pilar Llamas, Federico Rojo, Manuela Mollejo, Javier Menárguez, Javier Alves, Mónica García-Cosio, Miguel A. Piris, Socorro M. Rodríguez-Pinilla

Blood (2014) 123 (18): 2893–2894.

https://doi.org/10.1182/blood-2014-02-555946

Published: 2014

Includes: Supplemental data

Journal Articles

Five Pro-Inflammatory Molecules Polymorphisms Analysis in Ischemic Cerebrovascular Disease (ICD).

Vanessa P. Moreno, Aránzazu García-Raso, María José García-Bueno, Araceli García, Carmen Sánchez, Dolores Subirá, Pilar LLamas

Blood (2009) 114 (22): 4514.

https://doi.org/10.1182/blood.V114.22.4514.4514

Published: 2009

NARROW

Safety Profile in Patients with Chronic Lymphocytic Leukemia Undergoing Treatment with 1st and 2nd Generation Bruton Tyrosine Kinase Inhibitors: Multicentric Real-World Experience

Feasibility of Electronic Patient-Reported Outcome (ePRO) Measurement Using PRO-CTCAE® Questionnaire to Improve Quality of Life Assessment and Healthcare Resources Management in Patients with Lymphoma Receiving Intravenous Chemotherapy

Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021

End-of-Life Care in Hospitalized Patients with Hematologic Malignancies: A Retrospective Unicentric Study

Machine Learning Model Defines Higher Risk of Venous Thromboembolism in Young Adults with Multiple Myeloma

Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies

Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

Study of the Clinical Significance of the Length of FLT3-ITD in Acute Myeloid Leukemia Patients

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Inhibition of the Hedgehog Pathway Decreases the Quiescent CD34+CD38- Population in Acute Myeloid Leukemia

Comparation of Digital PCR and Quantitative Pcr for Molecular Monitorization of Chronic Myeloid Leukemia Patients

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Analysis of Primary Hemostasis Alterations Induced By Ibrutinib Assessed By Shutter Speed and Aggregometry Impedance

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

Five Pro-Inflammatory Molecules Polymorphisms Analysis in Ischemic Cerebrovascular Disease (ICD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only